Company / Free Cash Flow per Share
Kymera Therapeutics, Inc. Free Cash Flow per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$3.61
FY2025
5-year range
-$3.73 / $0.39
FY2021-FY2025
Trend
+3.2%
vs FY2024
Sector context
#162 of 192
Health Care
What the data says
Kymera Therapeutics, Inc.'s free cash flow per share of $-3.61 is lower than 84% of companies in the Health Care sector (FY2025). Free Cash Flow per Share has fluctuated over the past 7 years, ranging from $-3.73 in FY2024 to $10.23 in FY2019.
Based on SEC 10-K filings.
-3.61 in FY2025.
Declined from $-2.86 to $-3.61 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 192This company -$3.61 Sector average $3.32
▼
-208.8% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 3.2% year-over-year.
- Ranks #162 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2019.
- Lowest free cash flow per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 3.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.61 | +3.2% |
| FY2024 | -$3.73 | -30.4% |
| FY2023 | -$2.86 | +5.4% |
| FY2022 | -$3.03 | -874.6% |
| FY2021 | $0.39 | -95.7% |
| FY2020 | $9.00 | -12.0% |
| FY2019 | $10.23 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 30, 2026